S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
NYSE:MDC

M.D.C. - MDC Stock Forecast, Price & News

$38.87
+0.81 (+2.13%)
(As of 03/31/2023 04:33 PM ET)
Add
Compare
Today's Range
$38.14
$38.89
50-Day Range
$35.49
$41.16
52-Week Range
$27.04
$41.41
Volume
536,865 shs
Average Volume
610,382 shs
Market Capitalization
$2.84 billion
P/E Ratio
5.07
Dividend Yield
5.15%
Price Target
$27.50

M.D.C. MarketRank™ Forecast

Analyst Rating
Hold
1.50 Rating Score
Upside/​Downside
28.3% Downside
$27.50 Price Target
Short Interest
Healthy
4.64% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.44mentions of M.D.C. in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$582,299 Sold Last Quarter
Proj. Earnings Growth
17.72%
From $2.54 to $2.99 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.40 out of 5 stars

Construction Sector

36th out of 106 stocks

Operative Builders Industry

9th out of 17 stocks


MDC stock logo

About M.D.C. (NYSE:MDC) Stock

M.D.C. Holdings, Inc. engages in proving homebuilding and financial services. It operates through the following business segments: West, Mountain, and East. The West segment includes operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, and Washington. The Mountain segment refers to the operations in Colorado, Idaho, and Utah. The East segment operates in Alabama, Florida, Maryland, Pennsylvania, Tennessee, and Virginia. The company was founded by Larry A. Mizel in 1972 and is headquartered in Denver, CO.

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

3 Undervalued Dividend Payers For Volatile Market Conditions (MDC)
M.D.C., Radian, and Century Communities are undervalued stocks, going by price-to-book ratios. All pay a dividend and all are in the home-buying industry.
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
M.D.C. Holdings, Inc. (MDC) Q4 Earnings Lag Estimates
See More Headlines
Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter.

MDC Company Calendar

Last Earnings
1/31/2023
Ex-Dividend for 2/22 Dividend
2/07/2023
Dividend Payable
2/22/2023
Today
3/31/2023
Next Earnings (Confirmed)
5/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Operative builders
Sub-Industry
Homebuilding
CUSIP
55267610
Employees
1,643
Year Founded
1972

Price Target and Rating

Average Stock Price Forecast
$27.50
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
-28.3%
Consensus Rating
Hold
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$562.14 million
Pretax Margin
13.29%

Debt

Sales & Book Value

Annual Sales
$5.72 billion
Cash Flow
$8.11 per share
Book Value
$42.60 per share

Miscellaneous

Free Float
56,059,000
Market Cap
$2.80 billion
Optionable
Optionable
Beta
1.36

Social Links


Key Executives

  • David D. Mandarich
    President, Chief Executive Officer & Director
  • Robert Nathaniel MartinRobert Nathaniel Martin
    Chief Financial Officer & Senior Vice President
  • Krista Montgomery
    Chief Human Resources Officer & Senior VP
  • Michael L. Kaplan
    Senior Vice President & General Counsel
  • Derek R. Kimmerle
    Chief Accounting Officer, VP & Controller













MDC Stock - Frequently Asked Questions

Should I buy or sell M.D.C. stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last twelve months. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View MDC analyst ratings
or view top-rated stocks.

What is M.D.C.'s stock price forecast for 2023?

4 brokers have issued 1-year price objectives for M.D.C.'s stock. Their MDC share price forecasts range from $27.00 to $28.00. On average, they predict the company's share price to reach $27.50 in the next twelve months. This suggests that the stock has a possible downside of 28.2%.
View analysts price targets for MDC
or view top-rated stocks among Wall Street analysts.

How have MDC shares performed in 2023?

M.D.C.'s stock was trading at $31.60 on January 1st, 2023. Since then, MDC stock has increased by 21.1% and is now trading at $38.28.
View the best growth stocks for 2023 here
.

Are investors shorting M.D.C.?

M.D.C. saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 2,510,000 shares, an increase of 15.7% from the January 31st total of 2,170,000 shares. Based on an average daily volume of 521,000 shares, the days-to-cover ratio is currently 4.8 days. Currently, 4.4% of the shares of the stock are sold short.
View M.D.C.'s Short Interest
.

When is M.D.C.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our MDC earnings forecast
.

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings results on Tuesday, January, 31st. The construction company reported $1.08 earnings per share for the quarter, missing analysts' consensus estimates of $1.53 by $0.45. The construction company earned $1.49 billion during the quarter, compared to the consensus estimate of $1.31 billion. M.D.C. had a trailing twelve-month return on equity of 19.24% and a net margin of 9.83%. M.D.C.'s revenue was up 3.6% compared to the same quarter last year. During the same period last year, the company posted $2.21 earnings per share.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. announced a quarterly dividend on Monday, January 23rd. Investors of record on Wednesday, February 8th will be given a dividend of $0.50 per share on Wednesday, February 22nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 5.22%. The ex-dividend date of this dividend is Tuesday, February 7th.
Read our dividend analysis for MDC
.

Is M.D.C. a good dividend stock?

M.D.C. (NYSE:MDC) pays an annual dividend of $2.00 per share and currently has a dividend yield of 5.25%. MDC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 26.08%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MDC will have a dividend payout ratio of 66.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDC.

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by a variety of retail and institutional investors. Top institutional investors include Moneta Group Investment Advisors LLC (11.48%), Dimensional Fund Advisors LP (7.01%), Hamlin Capital Management LLC (2.31%), Principal Financial Group Inc. (2.24%), Morgan Stanley (1.56%) and Geode Capital Management LLC (1.44%). Insiders that own company stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends
.

How do I buy shares of M.D.C.?

Shares of MDC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $38.28.

How much money does M.D.C. make?

M.D.C. (NYSE:MDC) has a market capitalization of $2.80 billion and generates $5.72 billion in revenue each year. The construction company earns $562.14 million in net income (profit) each year or $7.67 on an earnings per share basis.

How many employees does M.D.C. have?

The company employs 1,643 workers across the globe.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The official website for the company is www.mdcholdings.com. The construction company can be reached via phone at (303) 773-1100, via email at ir@mdch.com, or via fax at 303-771-3461.

This page (NYSE:MDC) was last updated on 3/31/2023 by MarketBeat.com Staff